MassMutual Private Wealth & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-288
Closed -$9.05K – 2379
2026
Q2
$9.05K Hold
288
– – ﹤0.01% 1446
2026
Q1
$7.13K Buy
288
+43
+18% +$1.02K ﹤0.01% 1520
2025
Q4
$5.72K Hold
245
– – ﹤0.01% 1628
2025
Q3
$4.83K Sell
245
-5
-2% -$103 ﹤0.01% 1686
2025
Q2
$5.42K Sell
250
-14
-5% -$330 ﹤0.01% 1609
2025
Q1
$6.4K Buy
264
+19
+8% +$428 ﹤0.01% 1484
2024
Q4
$5.11K Hold
245
– – ﹤0.01% 1527
2024
Q3
$4.87K Hold
245
– – ﹤0.01% 1395
2024
Q2
$3.8K Hold
245
– – ﹤0.01% 1409
2024
Q1
$3.9K Hold
245
– – ﹤0.01% 1349
2023
Q4
$4.12K Buy
245
+67
+38% +$916 ﹤0.01% 1289
2023
Q3
$2.08K Hold
178
– – ﹤0.01% 1493
2023
Q2
$2.39K Sell
178
-94
-35% -$1.35K ﹤0.01% 1424
2023
Q1
$4.51K Hold
272
– – ﹤0.01% 1176
2022
Q4
$5K Buy
272
+63
+30% +$970 ﹤0.01% 976
2022
Q3
$3K Buy
+209
New +$2.48K ﹤0.01% 1072
2022
Q1
– Sell
-85
Closed -$1K – 1532
2021
Q4
$1K Buy
+85
New +$559 ﹤0.01% 1194

Other funds holding CPRX

MassMutual Private Wealth & Trust's CPRX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 288 shares — an estimated $9.05K sold.

MassMutual Private Wealth & Trust first reported a position in CPRX in Q4 2021 and held it in 17 quarters. The position peaked at $9.05K in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.

  • MassMutual Private Wealth & Trust reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 288 Catalyst Pharmaceutical shares in Q3 2026, an estimated $9.05K.
  • MassMutual Private Wealth & Trust first reported a position in Catalyst Pharmaceutical in Q4 2021 and held it in 17 quarters.
  • MassMutual Private Wealth & Trust's Catalyst Pharmaceutical position peaked at $9.05K in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.